Considerations in the Preclinical Assessment of the Safety of Antisense Oligonucleotides.

Goyenvalle A, Jimenez-Mallebrera C, van Roon W, Sewing S, Krieg AM, Arechavala-Gomeza V, Andersson P.

DOI: 10.1089/nat.2022.0061
Published: 2022-12-28
Container: Nucleic Acid Ther
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1089/nat.2022.0061,
  title = {Considerations in the Preclinical Assessment of the Safety of Antisense Oligonucleotides.},
  author = {Goyenvalle A and  Jimenez-Mallebrera C and  van Roon W and  Sewing S and  Krieg AM and  Arechavala-Gomeza V and  Andersson P.},
  year = {2023},
  journal = {Nucleic Acid Ther},
  doi = {10.1089/nat.2022.0061},
  url = {https://doi.org/10.1089/nat.2022.0061}
}

RIS

TY  - JOUR
TI  - Considerations in the Preclinical Assessment of the Safety of Antisense Oligonucleotides.
AU  - Goyenvalle A
AU  -  Jimenez-Mallebrera C
AU  -  van Roon W
AU  -  Sewing S
AU  -  Krieg AM
AU  -  Arechavala-Gomeza V
AU  -  Andersson P.
PY  - 2023
JO  - Nucleic Acid Ther
DO  - 10.1089/nat.2022.0061
UR  - https://doi.org/10.1089/nat.2022.0061
ER  -

APA

A, G., C, J., W, V. R., S, S., AM, K., V, A., & P., A. (2023). Considerations in the Preclinical Assessment of the Safety of Antisense Oligonucleotides.. Nucleic Acid Ther. https://doi.org/10.1089/nat.2022.0061

Source records

europe-pmc · retrieved 2026-09-27T08:45:34.350Z
hal · retrieved 2026-09-27T08:45:34.391Z